- Home
- QGEN vs EVR Comparison
QGEN vs EVR Comparison
Compare QGEN & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- EVR
- Stock Information
- Founded
- QGEN 1986
- EVR 1995
- Country
- QGEN Netherlands
- EVR United States
- Employees
- QGEN N/A
- EVR N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- EVR Investment Managers
- Sector
- QGEN Health Care
- EVR Finance
- Exchange
- QGEN Nasdaq
- EVR Nasdaq
- Market Cap
- QGEN 10.7B
- EVR 11.7B
- IPO Year
- QGEN 1996
- EVR 2006
- Fundamental
- Price
- QGEN $45.59
- EVR $295.66
- Analyst Decision
- QGEN Buy
- EVR Buy
- Analyst Count
- QGEN 7
- EVR 9
- Target Price
- QGEN $50.68
- EVR $320.11
- AVG Volume (30 Days)
- QGEN 1.3M
- EVR 447.6K
- Earning Date
- QGEN 11-04-2025
- EVR 10-29-2025
- Dividend Yield
- QGEN 3.40%
- EVR 1.14%
- EPS Growth
- QGEN 331.20
- EVR 61.11
- EPS
- QGEN 1.84
- EVR 12.55
- Revenue
- QGEN $2,070,781,000.00
- EVR $3,542,875,000.00
- Revenue This Year
- QGEN $7.37
- EVR $24.72
- Revenue Next Year
- QGEN $5.65
- EVR $17.06
- P/E Ratio
- QGEN $24.84
- EVR $23.57
- Revenue Growth
- QGEN 5.32
- EVR 27.03
- 52 Week Low
- QGEN $37.63
- EVR $148.63
- 52 Week High
- QGEN $51.88
- EVR $364.42
- Technical
- Relative Strength Index (RSI)
- QGEN 50.80
- EVR 41.52
- Support Level
- QGEN $43.59
- EVR $292.97
- Resistance Level
- QGEN $45.36
- EVR $324.28
- Average True Range (ATR)
- QGEN 1.04
- EVR 12.50
- MACD
- QGEN 0.08
- EVR -0.18
- Stochastic Oscillator
- QGEN 59.41
- EVR 11.61
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About EVR Evercore Inc.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.